Randall Owen, MD
img_Randall Owen
Are you a patient?
Radiofrequency Ablation (RFA) of Head and Neck Cancer (HNC)

Dr. Owen carried out the first series of RFA on advanced HNC for patients with no other good treatment options.  There were some excellent results such as relief of pain and shrinkage or destruction of tumor.  There were also some complications which was expected given that this treatment is novel.  Further study is needed to refine the techniques to make it an appropriate option for patients with advanced disease.

Parathyroid Surgery

Dr. Owen presented his series of nearly 400 parathyroid operations at the 2009 American Head and Neck Society annual meeting.  He showed that measuring intraoperative PTH levels seven minutes after lesion excision allowed early determination of cure 80% of the time.  99% of patients were cured of their disease.

Thyroid Surgery
Dr. Owen is the principal investigator for a prospective trial investigating whether intraoperative video laryngoscopy improves recurrent laryngeal nerve monitoring during thyroid surgery.

MD, Columbia University College of Physicians & Surgeons

MS, Albert Einstein College of Medicine, Clinical Research

Residency, Surgery (General Surgery), Albert Einstein College of Medicine-Yeshiva University

Fellowship, Otolaryngology, Head And Neck Surgery, Albert Einstein College of Medicine-Yeshiva University


American Board of Surgery


“Attending of the Year” Award


Christian Medical and Dental Society Short-Term Mission Scholarship


MAP-Reader's Digest International Fellowship Recipient

Surgical Education Award

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Owen did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.